Assessing Cognex: Insights From 10 Financial Analysts
In the latest quarter, 10 analysts provided ratings for Cognex (NASDAQ:CGNX), showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 3 | 3 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 3 | 2 | 1 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $59.0, a high estimate of $70.00, and a low estimate of $42.00. Witnessing a positive shift, the current average has risen by 23.77% from the previous average price target of $47.67.
Decoding Analyst Ratings: A Detailed Look
The analysis of recent analyst actions sheds light on the perception of Cognex by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Tomohiko Sano | JP Morgan | Announces | Neutral | $55.00 | - |
| Matthew Summerville | DA Davidson | Raises | Neutral | $55.00 | $38.00 |
| Joe Ritchie | Goldman Sachs | Raises | Buy | $68.00 | $50.00 |
| Helen Fang | HSBC | Raises | Buy | $68.00 | $47.00 |
| Guy Hardwick | Barclays | Raises | Overweight | $61.00 | $54.00 |
| Ken Newman | Keybanc | Raises | Overweight | $70.00 | $50.00 |
| James Ricchiuti | Needham | Raises | Buy | $67.00 | $47.00 |
| Guy Hardwick | Barclays | Lowers | Overweight | $54.00 | $56.00 |
| Jamie Cook | Truist Securities | Lowers | Hold | $42.00 | $45.00 |
| Joe Ritchie | Goldman Sachs | Raises | Buy | $50.00 | $42.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Cognex. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Cognex compared to the broader market.
- Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Cognex's stock. This examination reveals shifts in analysts' expectations over time.
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Cognex's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Cognex analyst ratings.
Discovering Cognex: A Closer Look
Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. Geographically, it operates in United states, Europe, Greater China and others. Cognex generates the maximum proportion of its sales in the United States and Europe.
Cognex: Financial Performance Dissected
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Cognex displayed positive results in 3M. As of 31 December, 2025, the company achieved a solid revenue growth rate of approximately 9.86%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Cognex's net margin excels beyond industry benchmarks, reaching 12.94%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Cognex's ROE stands out, surpassing industry averages. With an impressive ROE of 2.19%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Cognex's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.63%, the company showcases efficient use of assets and strong financial health.
Debt Management: Cognex's debt-to-equity ratio is below the industry average. With a ratio of 0.05, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
The Core of Analyst Ratings: What Every Investor Should Know
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.